Showing results (631-640 of 673) with videos related to

Sort By:
Pageof 68
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve DiseaseNicolas Gendron, Mickael Rosa, Adeline Blandinieres, et al.
Circulation|February 13, 2015
Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1Elena Osto, Petia Doytcheva, Caroline Corteville, et al.
Scientific Reports|March 22, 2019
Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer's disease mouse modelJeroen Bogie, Cindy Hoeks, Melissa Schepers, et al.
International Journal of Cardiology|February 19, 2020
Clinical significance of electrocardiographic markers of myocardial damage prior to aortic valve replacementAugustin Coisne, Sandro Ninni, François Pontana, et al.
Obesity (Silver Spring, Md.)|September 6, 2023
The tissue-specific metabolic effects of the PPARα agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover studyVera H W de Wit-Verheggen, Froukje Vanweert, Juho Raiko, et al.
The Journal of Clinical Investigation|December 1, 2020
TREM-1 orchestrates angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysmMarie Vandestienne, Yujiao Zhang, Icia Santos-Zas, et al.
Cardiovascular Research|July 14, 2025
Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradationSrividya Velagapudi, Melroy X Miranda, Priyanka Adla, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
Bioorganic & Medicinal Chemistry|August 5, 2006
Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonistsElodie Blanc-Delmas, Nicolas Lebegue, Valérie Wallez, et al.
Pageof 68